MX369548B - Gel oral de un inhibidor de la fosfodiesterasa. - Google Patents
Gel oral de un inhibidor de la fosfodiesterasa.Info
- Publication number
- MX369548B MX369548B MX2016004450A MX2016004450A MX369548B MX 369548 B MX369548 B MX 369548B MX 2016004450 A MX2016004450 A MX 2016004450A MX 2016004450 A MX2016004450 A MX 2016004450A MX 369548 B MX369548 B MX 369548B
- Authority
- MX
- Mexico
- Prior art keywords
- phosphodiesterase inhibitor
- oral gel
- gel
- elaboration
- helpful
- Prior art date
Links
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 title 1
- 229940041672 oral gel Drugs 0.000 title 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 abstract 2
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940125532 enzyme inhibitor Drugs 0.000 abstract 1
- 239000002532 enzyme inhibitor Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960003310 sildenafil Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una novedosa composición farmacéutica oral en forma de gel que comprende un agente inhibidor selectivo de la enzima fosfodiesterasa, preferentemente sildenafil y/o sus sales farmacéuticamente aceptables, un agente mejorador del sabor y un agente modificador de la viscosidad. Dicha composición presenta aplicación en el campo de la medicina y resulta útil para la preparación de un medicamento útil para el tratamiento de la disfunción eréctil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2016004450A MX369548B (es) | 2016-04-07 | 2016-04-07 | Gel oral de un inhibidor de la fosfodiesterasa. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2016004450A MX369548B (es) | 2016-04-07 | 2016-04-07 | Gel oral de un inhibidor de la fosfodiesterasa. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016004450A MX2016004450A (es) | 2017-05-08 |
| MX369548B true MX369548B (es) | 2019-11-11 |
Family
ID=59366608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016004450A MX369548B (es) | 2016-04-07 | 2016-04-07 | Gel oral de un inhibidor de la fosfodiesterasa. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX369548B (es) |
-
2016
- 2016-04-07 MX MX2016004450A patent/MX369548B/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX2016004450A (es) | 2017-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20220130B1 (ar) | مجموعات تترا هيدروفيوران بها استبدال في صورة عوامل تعديل لقنوات الصوديوم | |
| PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
| MX2024010140A (es) | Nuevos metodos. | |
| MY199967A (en) | Combinations of lsd1 inhibitors for use in the treatment of solid tumors | |
| EA201892395A1 (ru) | Лекарственные составы ингибитора lsd1 | |
| WO2016196776A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| WO2020140054A8 (en) | Cyclin-dependent kinase inhibitors | |
| PH12016502355B1 (en) | Pharmaceutical composition | |
| PH12017500724B1 (en) | Carbazole derivatives | |
| MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
| PH12021551302A1 (en) | COMPOUNDS AND THEIR USE FOR THE TREATMENT OF a1-ANTITRYPSIN DEFICIENCY | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| MX385518B (es) | FORMULACIÓN QUE TIENE CARACTERÍSTICAS MEJORADAS DE LIBERACIÓN DE FÁRMACOS pH DEPENDIENTES, QUE CONTIENEN ESOMEPRAZOL O UNA DE SUS SALES FARMACÉUTICAS ACEPTABLE. | |
| PH12020552274A1 (en) | Formulations of an axl/mer inhibitor | |
| PH12019501999A1 (en) | Pyrazole derivatives as bromodomain inhibitors | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| MX2016004450A (es) | Gel oral de un inhibidor de la fosfodiesterasa. | |
| TW201613926A (en) | Inhibitors of bruton's tyrosine kinase | |
| EA201891739A1 (ru) | ПРИМЕНЕНИЕ СТИМУЛЯТОРОВ sGC ДЛЯ ЛЕЧЕНИЯ НЕАЛКОГОЛЬНОГО СТЕАТОГЕПАТИТА (NASH) | |
| EA202191159A1 (ru) | Лечение и профилактика преждевременной эякуляции (pe) | |
| MX2018001528A (es) | Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña. | |
| EA202090268A1 (ru) | Карбоксамиды в качестве модуляторов натриевых каналов | |
| HK1233927A1 (en) | Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |